NasdaqGS:VRTXBiotechs
Is It Time To Reassess Vertex (VRTX) After Recent Share Price Weakness?
If you are wondering whether Vertex Pharmaceuticals at around US$425 per share offers good value or is already pricing in too much optimism, this article breaks down what the current stock price may be implying.
The stock is around US$425 after a 0.6% slip over the last week, a 1.6% decline over the last month and a 6.0% decline year to date. The 1 year return sits at 1.1%, the 3 year at 21.3% and the 5 year at 98.3%.
Recent attention around Vertex has focused on its product pipeline and...